Balyasny Asset Management’s DTRT Health Acquisition Corp. Warrant DTRTW Stock Holding History

Balyasny Asset Management’s Portfolio DTRTW Stock Details DTRTW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-175,000	Closed	-$38.5K	–	3409
2022 Q4	$38.5K	Hold	175,000	–	–	﹤0.01%	2384
2022 Q3	$35K	Hold	175,000	–	–	﹤0.01%	2517
2022 Q2	$11K	Hold	175,000	–	–	﹤0.01%	2576
2022 Q1	$37K	Hold	175,000	–	–	﹤0.01%	2283
2021 Q4	$84K	Buy	+175,000	New	+$92.7K	﹤0.01%	1988

Balyasny Asset Management's DTRTW Position: Q1 2023 in Review

Balyasny Asset Management sold out of DTRT Health Acquisition Corp. Warrant (DTRTW) in Q1 2023, closing a stake of 175,000 shares — an estimated $38.5K sold.

Balyasny Asset Management first reported a position in DTRTW in Q4 2021 and held it in 5 quarters. The position peaked at $84K in Q4 2021. 0 funds tracked by Wall St. Rank hold DTRTW as of Q1 2023.

Balyasny Asset Management reported no remaining DTRT Health Acquisition Corp. Warrant position as of Q1 2023 after selling out during the quarter.
Balyasny Asset Management sold 175,000 DTRT Health Acquisition Corp. Warrant shares in Q1 2023, an estimated $38.5K.
Balyasny Asset Management first reported a position in DTRT Health Acquisition Corp. Warrant in Q4 2021 and held it in 5 quarters.
Balyasny Asset Management's DTRT Health Acquisition Corp. Warrant position peaked at $84K in Q4 2021.
0 funds tracked by Wall St. Rank held DTRT Health Acquisition Corp. Warrant as of Q1 2023.

Based on Balyasny Asset Management's 13F filing for Q1 2023, filed 15 May 2023.